Used in pharmaceutical research as a potent and selective inhibitor of the kinase enzyme DYRK1A, which is implicated in neurological disorders such as Down syndrome and Alzheimer’s disease. Shows promise in modulating brain function and improving cognitive performance in preclinical models. Also investigated for its potential in cancer therapy due to its ability to interfere with cell proliferation pathways. Its structural properties make it suitable for blood-brain barrier penetration, enhancing its utility in central nervous system drug development.